Protalix BioTherapeutics to Present at the H.C. Wainwright 6th Annual Israel Conference
- Thursday, November 5, 2020, 7:00
- Finance
- Add a comment
CARMIEL, Israel, Nov. 5, 2020 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based…
About the Author
adminasapcorp has written 39134 stories on this site.